Some feel that the critic’s arguments are not to be dismissed lightly. They say that treatment and drugs should go through a thorough process before approving them. They also say that clinical trials should be conducted and evaluated properly if side effects and outer limits of the drug’s efficacy is to be known. Manufacturers need to be held accountable. However, these aren’t safeguards that should apply to terminally ill patients.
The House file 878 won’t impose the right-to-try legislation on states that haven’t authorize it. However, the federal government is required to allow experimental treatments to be used on patients whose doctors certify that other available options have been exhausted. The legislation also requires that the treatment must have passes clinical trials and in the process of obtaining approval from the FDA.